Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A Single Arm, Open-Label, Phase 1b Trial of Epcoritamab in Pediatric Patients With Relapsed/Refractory Aggressive Mature B-cell Neoplasms
Protocol ID
M20-429
Disease (Sub Disease)
Indolent Non-Hodgkin Lymphoma
Diagnosis Stage
Relapsed/refractory
Location
NSW, WA
Sponsor
AbbVie
Collaborators
Genmab
Trial Status
Open
Sites
The Children's Hospital at Westmead
Perth Children's Hospital
Study Type
Treatment
Phase
Phase 1/2
Age Eligibility
1 Year to 21 Year5
International registry ID's
NCT05206357
Back to Registry
Study Title A Single Arm Open-Label Phase 1b Trial of Epcoritamab in Pediatric Patients With Relapsed/Refractory Aggressive Mature B-cell Neoplasms
Protocol ID M20-429
Disease (Sub Disease) Indolent Non-Hodgkin Lymphoma
Diagnosis Stage Relapsed/refractory
Location NSW / WA
Sponsor AbbVie
Collaborators Genmab
Links https://clinicaltrials.gov/ct2/show/NCT05206357
Trial Status Open
Trial Open Date 29/09/2022
Sites The Children's Hospital at Westmead / Perth Children's Hospital
Study Type Treatment
Phase Phase 1/2
Age Eligibility 1 Year to 21 Year5
International registry ID's NCT05206357